Solid Tumour Studies program  

5 studies included

Trialx QA Program  

This Program is for Testing purpose Only.

My program 1  

Product demo program.

PPD Multiprotocol Prescreening Website  

Multi-study MS  

A clinical research study testing multiple MS trials

Evaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Cancer  

The primary objective of this study is to evaluate the safety and tolerability of BGT007H cell therapy in patients with recurrent/refractory pancreatic cancer.

The 23andMe Lung Cancer Genetic Study

-style:initial;text-decoration-thickness:initial;text-indent:0px;text-transform:none;white-space:normal;widows:2;word-spacing:0px;">the lung cancer community and scientists want to learn more about the genetics of

Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab or Ramucirumab and Pembrolizumab in Pretreated Patients With NSQ NSCLC (CARMEN-LC04)  

durability of the response to treatment with tusamitamab ravtansine in combination with ramucirumab. To assess anti-tumor activity of tusamitamab ravtansine in combination with ramucirumab on

Mechanistic Study of the Effect of Itepekimab on Airway Inflammation in Patients With COPD  

approximately 36 weeks:

A Study to Evaluate SAR441566 Efficacy and Safety in Adults With Rheumatoid Arthritis  

This is a parallel group, Phase 2, randomized, double-blind, placebo controlled, 5-arm, international, multicenter, 12-week proof of concept, dose finding study. It is designed to assess efficacy and safety of treatment with SAR441566 for 12 weeks. It will be conducted in male and female adult participants with moderate-to-severe rheumatoid arthritis …